Sign in
Taking peopleNo phase

Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

Key facts

Who runs it
Sohag University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
150 people, planned
Started
13 May 2025
Planned end
25 Nov 2025
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection
  • Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection
  • Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection
Record updated
1 July 2025

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age: >18 years old
  • H. pylori infection: Confirmed by histopathology or non-invasive tests (e.g., stool antigen test)

Who cannot take part

  • Prior H. pylori treatment: Previous treatment for H. pylori infection
  • Allergies: Known allergies to study medications or components
  • Patients cannot finish treatment course
  • Patient missed follow up
  • Patients refusing or neglecting test of cure for H. pylori

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .

The 3 groups in the trial

  • Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infectionExisting treatment, for comparison

    we assess the efficacy of Vonoprazan based dual therapy for eradication of Helicobacter Pylori infection in naive patient.

  • Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infectionExisting treatment, for comparison

    we assess the efficacy of Vonoprazan based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

  • Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infectionExisting treatment, for comparison

    we assess the efficacy of proton pump inhibitors (PPI) based dual therapy for eradication of Helicobacter Pylori infection in naive patient.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy of Vonoprazan Based Dual and Triple Therapy for Naive Patient With Helicobacter Pylori Infection
Record updated
1 July 2025